US4829311020
US4829311020
Kailera Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 158.340.000 | -- | -- | |
| Operating Income | -158.340.000 | -- | -- |
| Pretax Income | -148.955.000 | -- | -- |
| Net Income Common Stockholders | -148.955.000 | -- | -- |
| -- | -- | -- | |
| -- | -- | -- |